This is the authors' abstract. We don't add key points for this paper.
These findings identify AhR inhibition as a novel therapeutic approach to overcome immune resistance in various types of cancers.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kober et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: